LXRX•benzinga•
Reported Sunday, Lexicon Pharmaceuticals To Present Topline Data From Phase 2b Study Of Pilavapadin In Diabetic Peripheral Neuropathic Pain
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 3, 2025 by benzinga